University of Birmingham
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From University of Birmingham
The firms hope academic research can yield first-in-class therapies and spinout companies. Also, Yale unveils research alliances with three biotechs.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.
START-UP's comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies sectors.
Harnessing the power of Darwinian natural selection to find therapeutic oncolytic adenoviruses is one of the aims of the Oxford, UK-based start-up PsiOxus Therapeutics Ltd. Another is to develop the first therapies for the wasting syndromes cachexia and sarcopenia.
- Academic and Research Institutions
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.